Ten63 Therapeutics

Ten63 Therapeutics

BiotechDurhamSeries B
ten63tx.com

AI platform for cancer drug discovery

At a glance

  • Founded: 2018
  • HQ: Durham
  • Sector: Biotech
  • Stage: Series B
  • Total raised: $45M
  • Last round: Growth
  • Team size: 1-19
  • Affiliation: Duke

The rest of this record is behind a free account.

Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately, and I read every signup.